EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

m 6 A‐Mediated Glycolysis by IL‐37 Drives T Cell Metabolic Reprogramming to Regulate Colitis

Xiaoyan Wang, Jiadong Yu, Guolin Li, Ya Li, Fanlian Zeng, Jing Hu, Yifan Zhou, Chengcheng Yue, Qixiang Zhao, Chen Zhang, Hong Zhou, Fulei Zhao und 15 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202520472 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Xiaoyan Wang und 26 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Ch…. Hauptthemen laut MEDLINE: Colitis, Interleukin-1, Adenosine, Glycolysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N6‐methyladenosine (m 6 A) modification and T‐cell metabolic reprogramming are increasingly recognized as critical drivers of inflammatory bowel disease (IBD). However, how the anti‐inflammatory cytokine interleukin‐37 intersects with m 6 A‐mediated metabolic regulation remains unclear. Here, we show that IL‐37 alleviates colitis by reducing global m 6 A levels and reshaping CD4 + T‐cell metabolism. Mechanistically, IL‐37 signals through its receptor SIGIRR to inhibit IRAK4 and JNK phosphorylation, suppress NF‐κB p65 activation, and downregulate METTL14, thereby decreasing m 6 A deposition. The IL‐37/METTL14 axis notably reduces m 6 A enrichment at the A2445 site in the 3′UTR of SLC2A1, destabilizing its mRNA and suppressing glycolysis. In vitro T‐cell polarization and adoptive transfer of METTL14‐overexpressing CD4 + T cells confirmed that this metabolic shift restrains Th1/Th17 differentiation while promoting Th2 expansion. Together, these findings reveal the IL‐37/SIGIRR–METTL14–m 6 A axis as a novel regulator of T‐cell metabolism and highlight SLC2A1 as a potential therapeutic target in IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColitisInterleukin-1AdenosineGlycolysisCD4-Positive T-LymphocytesInflammatory Bowel DiseasesAnimalsMiceMetabolic ReprogrammingHumansRNA MethylationMice, Inbred C57BL

Stichwörter der Autor:innen

IL‐37T cell metabolismcolitisglycolysism6A methylation

Substanzen

Interleukin-1AdenosineN-methyladenosine

Autor:innen und Institutionen

  • State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, China.
  • Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • CDUTCM-KEELE Joint Health and Medical Sciences Institute, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

ORCID-Profile: Jiong Li

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, X., Yu, J., Li, G., Li, Y., Zeng, F., Hu, J., Zhou, Y., Yue, C., Zhao, Q., Zhang, C., Zhou, H., Zhao, F., Hu, Y., Zhou, P., Gu, L., Feng, Y., He, M., Huang, S., Sun, X., …, & Li, J. (2026). m 6 A‐Mediated Glycolysis by IL‐37 Drives T Cell Metabolic Reprogramming to Regulate Colitis. Advanced Science. https://doi.org/10.1002/advs.202520472

Vancouver

Wang X, Yu J, Li G, Li Y, Zeng F, Hu J, et al. m 6 A‐Mediated Glycolysis by IL‐37 Drives T Cell Metabolic Reprogramming to Regulate Colitis. Advanced Science. 2026. doi:10.1002/advs.202520472

BibTeX
@article{Wang2026,
  author = {Wang, Xiaoyan and Yu, Jiadong and Li, Guolin and Li, Ya and Zeng, Fanlian and Hu, Jing and Zhou, Yifan and Yue, Chengcheng and Zhao, Qixiang and Zhang, Chen and Zhou, Hong and Zhao, Fulei and Hu, Yawen and Zhou, Pei and Gu, Linna and Feng, Yuting and He, Mingxiang and Huang, Shishi and Sun, Xiaochi and Wang, Xinmeng and Tang, Jie and Zeng, Xinyu and Wu, Wenling and Huang, Nongyu and Cui, Xinai and Cui, Kaijun and Li, Jiong},
  title = {m 6 A‐Mediated Glycolysis by IL‐37 Drives T Cell Metabolic Reprogramming to Regulate Colitis},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202520472}
}
Kostenlos starten →